Physician profile
Taylor Scheller
NPI 1225626633
$3,392.04
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,221 · 2022: $2,171.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $834.46 | 2021-2022 | |
| Ucb, INC. | $439.76 | 2021-2022 | |
| Abbvie INC. | $418.03 | 2021-2022 | |
| Pfizer INC. | $231.51 | 2021-2022 | |
| Lilly USA, LLC | $219.50 | 2021-2022 | |
| Glaxosmithkline, LLC. | $197.57 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $177.35 | 2021-2022 | |
| Horizon Therapeutics Plc | $151.93 | 2021-2022 | |
| Radius Health, INC. | $93.75 | 2022 | |
| Alexion Pharmaceuticals, INC. | $90.75 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $80.27 | 2021 | |
| Ferring Pharmaceuticals INC. | $78.48 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $63.44 | 2022 | |
| Sobi, INC | $61.34 | 2022 | |
| Ani Pharmaceuticals, INC. | $34.81 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $32.30 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $29.04 | 2022 | |
| Aurinia Pharma U.S., INC. | $28.75 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.79 | 2022 | |
| Janssen Biotech, INC. | $24.35 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $21.21 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $17.87 | 2022 | |
| Hikma Pharmaceuticals USA | $16.70 | 2022 | |
| Oxford Immunotec USA INC | $16.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $6.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Scheller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.